It’s being hailed as a significant step towards ending the global HIV epidemic. The United States Food and Drug Administration has approved an injectable drug that prevents HIV infection.
Known by the generic name lenacapavir, the drug was almost 100 per cent effective at preventing HIV transmission in large-scale trials. Developed by the pharmaceutical company Gilead, it is administered via two injections every year.
Chapters:
0:00 Injectable drug to prevent HIV approved in the US
1:08 Chris Beyrer, Duke Global Health Institute Director
For more news go to: http://www.dw.com/en/
Follow DW on social media:
►Instagram: https://www.instagram.com/dwnews
►TikTok: https://www.tiktok.com/@dwnews
►Facebook: https://www.facebook.com/deutschewellenews/
►Twitter: https://twitter.com/dwnews
Für Videos in deutscher Sprache besuchen Sie: https://www.youtube.com/dwdeutsch
Subscribe: https://www.youtube.com/user/deutschewelleenglish?sub_confirmation=1
